title: Atrial fibrillation: the beat is faster than the answers.
abstract: The prevalence of atrial fibrillation is much greater among persons with end-stage renal disease (ESRD) than among the general population. While significant advances have been made recently in the treatment of atrial fibrillation in the general population, we know very little about the treatment of atrial fibrillation among those with ESRD. This Commentary explores gaps in our knowledge of how to treat this vulnerable and sick population.
authors.affiliation: Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. szcze001@mc.duke.edu
authors.forename: Lynda A
authors.initials: LA
authors.lastname: Szczech
mesh_terms: D001281:Atrial Fibrillation / Q000453:epidemiology*; D003324:Coronary Artery Disease / Q000453:epidemiology*; D005260:Female; D006333:Heart Failure / Q000453:epidemiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy*; D008297:Male; D008484:Medicaid; D006278:Medicare; D006435:Renal Dialysis